chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: muscle aches; fever of 99.3; feeling very very sick; some weakness; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling very very sick), ASTHENIA (some weakness), CHILLS (chills), HEADACHE (headache) and MYALGIA (muscle aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced MALAISE (feeling very very sick), ASTHENIA (some weakness), CHILLS (chills), HEADACHE (headache) and PYREXIA (fever of 99.3). On an unknown date, the patient experienced MYALGIA (muscle aches). At the time of the report, MALAISE (feeling very very sick), ASTHENIA (some weakness), CHILLS (chills), HEADACHE (headache), MYALGIA (muscle aches) and PYREXIA (fever of 99.3) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Mar-2021, Body temperature: 99.3 (Inconclusive) 99.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported. Action taken with mRNA-1273 was not applicable.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Dyspnoea
Clinical narrative: Difficult breathing 20 minutes after receiving the vaccine; Dizziness 20 minutes after receiving the vaccine; weakness 20 minutes after receiving the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficult breathing 20 minutes after receiving the vaccine), DIZZINESS (Dizziness 20 minutes after receiving the vaccine) and ASTHENIA (weakness 20 minutes after receiving the vaccine.) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DYSPNOEA (Difficult breathing 20 minutes after receiving the vaccine), DIZZINESS (Dizziness 20 minutes after receiving the vaccine) and ASTHENIA (weakness 20 minutes after receiving the vaccine.). At the time of the report, DYSPNOEA (Difficult breathing 20 minutes after receiving the vaccine), DIZZINESS (Dizziness 20 minutes after receiving the vaccine) and ASTHENIA (weakness 20 minutes after receiving the vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were not provided. Treatment Medications were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Condition aggravated, Insomnia
Clinical narrative: Insomnia for "four nights in a row"; "much worse insomnia than usual"; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia for "four nights in a row") and CONDITION AGGRAVATED ("much worse insomnia than usual") in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Insomnia (Past medical history significant for recurrent insomnia.).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced INSOMNIA (Insomnia for "four nights in a row") and CONDITION AGGRAVATED ("much worse insomnia than usual"). At the time of the report, INSOMNIA (Insomnia for "four nights in a row") had resolved and CONDITION AGGRAVATED ("much worse insomnia than usual") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Myalgia, Peripheral swelling
Clinical narrative: swelling arm; redness; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling arm), ERYTHEMA (redness) and MYALGIA (muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling arm), ERYTHEMA (redness) and MYALGIA (muscle pain). At the time of the report, PERIPHERAL SWELLING (swelling arm), ERYTHEMA (redness) and MYALGIA (muscle pain) outcome was unknown. Not Provided          Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: COVID arm; the rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (COVID arm) and RASH (the rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (COVID arm) and RASH (the rash). At the time of the report, PAIN IN EXTREMITY (COVID arm) and RASH (the rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash at the injection site; Itching at the injection site; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and CHILLS (Chills). At the time of the report, VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia oral
Clinical narrative: red face; tingly lips; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (red face) and PARAESTHESIA ORAL (tingly lips) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ERYTHEMA (red face) and PARAESTHESIA ORAL (tingly lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 05-Mar-2021, ERYTHEMA (red face) and PARAESTHESIA ORAL (tingly lips) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Medications were not provided by the reporter.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site lymphadenopathy, Vaccination site pain
Clinical narrative: site of injection is sorel; Arm is Swelling; Under Arm is Painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (site of injection is sore), VACCINATION SITE LYMPHADENOPATHY (Arm is Swelling) and PAIN IN EXTREMITY (Under Arm is Painful) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M2A and 013M2A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (site of injection is sorel), VACCINATION SITE LYMPHADENOPATHY (Arm is Swelling) and PAIN IN EXTREMITY (Under Arm is Painful). At the time of the report, VACCINATION SITE PAIN (site of injection is sorel), VACCINATION SITE LYMPHADENOPATHY (Arm is Swelling) and PAIN IN EXTREMITY (Under Arm is Painful) outcome was unknown.            Concomitant Medications were not provided by the reporter. Treatment includes Tylenol ,Benadryl cream.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Tooth abscess
Clinical narrative: dental work after second dose; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH ABSCESS (dental work after second dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TOOTH ABSCESS (dental work after second dose). At the time of the report, TOOTH ABSCESS (dental work after second dose) outcome was unknown.            No concomitant medication was reported. Treatment Medication includes: Antibiotic for dental work.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: headaches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headaches) and FATIGUE (fatigue) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headaches) and FATIGUE (fatigue). At the time of the report, HEADACHE (headaches) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow-up was received on 03-may-2021 contains an updated event
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain
Clinical narrative: fatigue; injection site pain; Injection site soreness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), INJECTION SITE PAIN (injection site pain) and INJECTION SITE PAIN (Injection site soreness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (fatigue), INJECTION SITE PAIN (injection site pain) and INJECTION SITE PAIN (Injection site soreness). At the time of the report, FATIGUE (fatigue), INJECTION SITE PAIN (injection site pain) and INJECTION SITE PAIN (Injection site soreness) had resolved. Not Provided          Treatment information not provided. Concomitant medications were not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular)  was not applicable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Pain in extremity, Rash erythematous
Clinical narrative: very inflamed; sore arm; red rash on left arm, stomach and legs; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (very inflamed), PAIN IN EXTREMITY (sore arm) and RASH ERYTHEMATOUS (red rash on left arm, stomach and legs) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL and APIXABAN (ELIQUIS) for an unknown indication.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced INFLAMMATION (very inflamed). 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and RASH ERYTHEMATOUS (red rash on left arm, stomach and legs). On 28-Feb-2021, INFLAMMATION (very inflamed) and PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, RASH ERYTHEMATOUS (red rash on left arm, stomach and legs) outcome was unknown.            Treatment includes Triamcinolone.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Rash; Itching; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and PRURITUS (Itching) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash) and PRURITUS (Itching). At the time of the report, RASH (Rash) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported. No Treatment medicines were reported.   This case was linked to MOD-2021-067700 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vertigo in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vertigo. At the time of the report, vertigo outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications, laboratory details or treatment information reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Body temperature, Chills, Fatigue
Clinical narrative: runny nose; Loss of taste; Fatigue; Join pain; Muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), AGEUSIA (Loss of taste), FATIGUE (Fatigue), ARTHRALGIA (Join pain) and MYALGIA (Muscle pain) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Sleep disorder. Concomitant products included ENALAPRIL for Blood pressure management, VENLAFAXINE HYDROCHLORIDE (EFFEXOR SR) for Depression, TRAZODONE for Sleep disorder.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (Fatigue), ARTHRALGIA (Join pain), MYALGIA (Muscle pain) and CHILLS (Chills). On 05-Mar-2021, the patient experienced RHINORRHOEA (runny nose) and AGEUSIA (Loss of taste). The patient was treated with PARACETAMOL (TYLENOL) on 03-Mar-2021 at a dose of UNK dosage form; PARACETAMOL (TYLENOL) on 04-Mar-2021 at an unspecified dose and frequency and ZINC at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (runny nose), AGEUSIA (Loss of taste), FATIGUE (Fatigue), ARTHRALGIA (Join pain), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 97.3 (Inconclusive) 97.3 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient experienced loss of taste and runny nose for which she used Saline in nose and Elderberry liquid syrup.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rhinorrhoea
Clinical narrative: runny nose; Loss of taste; Fatigue; Join pain; Muscle pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), AGEUSIA (Loss of taste), FATIGUE (Fatigue), ARTHRALGIA (Join pain) and MYALGIA (Muscle pain) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Sleep disorder. Concomitant products included ENALAPRIL for Blood pressure management, VENLAFAXINE HYDROCHLORIDE (EFFEXOR SR) for Depression, TRAZODONE for Sleep disorder.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced FATIGUE (Fatigue), ARTHRALGIA (Join pain), MYALGIA (Muscle pain) and CHILLS (Chills). On 05-Mar-2021, the patient experienced RHINORRHOEA (runny nose) and AGEUSIA (Loss of taste). The patient was treated with PARACETAMOL (TYLENOL) on 03-Mar-2021 at a dose of UNK dosage form; PARACETAMOL (TYLENOL) on 04-Mar-2021 at an unspecified dose and frequency and ZINC at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (runny nose), AGEUSIA (Loss of taste), FATIGUE (Fatigue), ARTHRALGIA (Join pain), MYALGIA (Muscle pain) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 97.3 (Inconclusive) 97.3 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient experienced loss of taste and runny nose for which she used Saline in nose and Elderberry liquid syrup.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site discomfort, Injection site swelling, Somnolence
Clinical narrative: Very sleepy after injection; Some discomfort at injection site; Felt tired for rest o f the day; Swelling at injection site; couldn't stay awake/drowsy; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Very sleepy after injection), SOMNOLENCE (couldn't stay awake/drowsy), INJECTION SITE DISCOMFORT (Some discomfort at injection site), INJECTION SITE SWELLING (Swelling at injection site) and FATIGUE (Felt tired for rest o f the day) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced SOMNOLENCE (couldn't stay awake/drowsy) and INJECTION SITE SWELLING (Swelling at injection site). On an unknown date, the patient experienced SOMNOLENCE (Very sleepy after injection), INJECTION SITE DISCOMFORT (Some discomfort at injection site) and FATIGUE (Felt tired for rest o f the day). At the time of the report, SOMNOLENCE (Very sleepy after injection), SOMNOLENCE (couldn't stay awake/drowsy), INJECTION SITE DISCOMFORT (Some discomfort at injection site), INJECTION SITE SWELLING (Swelling at injection site) and FATIGUE (Felt tired for rest o f the day) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Additional initial
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (shoulder pain). At the time of the report, ARTHRALGIA (shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Pruritus, Rash
Clinical narrative: legs started itching; both legs, from the knee down to his ankles, had red spots all over them; looks like a poison ivy rash - It's itching really bad; slight sore arm from the injection; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (legs started itching), ERYTHEMA (both legs, from the knee down to his ankles, had red spots all over them), RASH (looks like a poison ivy rash - It's itching really bad) and INJECTION SITE PAIN (slight sore arm from the injection) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (legs started itching), ERYTHEMA (both legs, from the knee down to his ankles, had red spots all over them), RASH (looks like a poison ivy rash - It's itching really bad) and INJECTION SITE PAIN (slight sore arm from the injection). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency and HYDROXYZINE at an unspecified dose and frequency. At the time of the report, PRURITUS (legs started itching), ERYTHEMA (both legs, from the knee down to his ankles, had red spots all over them), RASH (looks like a poison ivy rash - It's itching really bad) and INJECTION SITE PAIN (slight sore arm from the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Biopsy bone marrow, Blood test, Dizziness, Fatigue
Clinical narrative: slight fatigue; trouble getting out of bed; verge of passing out; sick to stomach immediately; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to stomach immediately), DIZZINESS (dizzy), LETHARGY (trouble getting out of bed), VERTIGO (verge of passing out) and FATIGUE (slight fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included Thalassemia minor (thalassemia minor-type B) since an unknown date, Neck discomfort (neck issues) since an unknown date and Pacemaker insertion (cardiac) (10-Feb.).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to stomach immediately) and DIZZINESS (dizzy). On 08-Mar-2021, the patient experienced LETHARGY (trouble getting out of bed) and VERTIGO (verge of passing out). On an unknown date, the patient experienced FATIGUE (slight fatigue). At the time of the report, ABDOMINAL DISCOMFORT (sick to stomach immediately), DIZZINESS (dizzy), LETHARGY (trouble getting out of bed) and VERTIGO (verge of passing out) had resolved and FATIGUE (slight fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy bone marrow: unknown (Inconclusive) 24-feb. On an unknown date, Blood test: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Event details were added and updated
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Vertigo
Clinical narrative: slight fatigue; trouble getting out of bed; verge of passing out; sick to stomach immediately; dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick to stomach immediately), DIZZINESS (dizzy), LETHARGY (trouble getting out of bed), VERTIGO (verge of passing out) and FATIGUE (slight fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included Thalassemia minor (thalassemia minor-type B) since an unknown date, Neck discomfort (neck issues) since an unknown date and Pacemaker insertion (cardiac) (10-Feb.).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (sick to stomach immediately) and DIZZINESS (dizzy). On 08-Mar-2021, the patient experienced LETHARGY (trouble getting out of bed) and VERTIGO (verge of passing out). On an unknown date, the patient experienced FATIGUE (slight fatigue). At the time of the report, ABDOMINAL DISCOMFORT (sick to stomach immediately), DIZZINESS (dizzy), LETHARGY (trouble getting out of bed) and VERTIGO (verge of passing out) had resolved and FATIGUE (slight fatigue) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy bone marrow: unknown (Inconclusive) 24-feb. On an unknown date, Blood test: normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Event details were added and updated
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: fast heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (fast heartbeat) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced TACHYCARDIA (fast heartbeat). At the time of the report, TACHYCARDIA (fast heartbeat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were not provided.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Insomnia, Nausea, Pyrexia
Clinical narrative: sleepless night; dizziness; diarrhea; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (sleepless night), DIZZINESS (dizziness), DIARRHOEA (diarrhea), NAUSEA (nausea) and PYREXIA (fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INSOMNIA (sleepless night), DIZZINESS (dizziness), DIARRHOEA (diarrhea), NAUSEA (nausea) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 05-Mar-2021, INSOMNIA (sleepless night), DIZZINESS (dizziness), DIARRHOEA (diarrhea), NAUSEA (nausea) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pruritus (itchy), pain (sore) and rash in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pruritus (itchy), pain (sore) and rash. The patient treated with Zyrtec (cetirizine hydrochloride), at an unspecified dose and frequency; and Tylenol (paracetamol), at an unspecified dose and frequency. At the time of the report, pruritus (itchy), pain (sore) and rash outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications reported.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: arm was itchy at the site of injection and there was a big red circle around the injection site; arm was itchy at the site of injection and there was a big red circle around the injection site; rea was swollen like a lump; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (arm was itchy at the site of injection and there was a big red circle around the injection site), INJECTION SITE ERYTHEMA (arm was itchy at the site of injection and there was a big red circle around the injection site) and INJECTION SITE SWELLING (rea was swollen like a lump) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced INJECTION SITE PRURITUS (arm was itchy at the site of injection and there was a big red circle around the injection site), INJECTION SITE ERYTHEMA (arm was itchy at the site of injection and there was a big red circle around the injection site) and INJECTION SITE SWELLING (rea was swollen like a lump). At the time of the report, INJECTION SITE PRURITUS (arm was itchy at the site of injection and there was a big red circle around the injection site), INJECTION SITE ERYTHEMA (arm was itchy at the site of injection and there was a big red circle around the injection site) and INJECTION SITE SWELLING (rea was swollen like a lump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Gouty arthritis
Clinical narrative: Severe gout in left feet and knee; This spontaneous case was reported by a consumer and describes the occurrence of GOUTY ARTHRITIS (Severe gout in left feet and knee) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced GOUTY ARTHRITIS (Severe gout in left feet and knee). The patient was treated with PREDNISONE at an unspecified dose and frequency and CAPSAICIN, MENTHOL, METHYL SALICYLATE (ULTRACIN) at an unspecified dose and frequency. At the time of the report, GOUTY ARTHRITIS (Severe gout in left feet and knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm was sore in the same muscle as the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore in the same muscle as the injection) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was sore in the same muscle as the injection). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (arm was sore in the same muscle as the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-063853 (E2B Linked Report).
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue, Somnolence
Clinical narrative: sleeping most of the day; no appetite; very weak; excessive fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping most of the day), DECREASED APPETITE (no appetite), ASTHENIA (very weak) and FATIGUE (excessive fatigue) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced SOMNOLENCE (sleeping most of the day), DECREASED APPETITE (no appetite), ASTHENIA (very weak) and FATIGUE (excessive fatigue). At the time of the report, SOMNOLENCE (sleeping most of the day), DECREASED APPETITE (no appetite), ASTHENIA (very weak) and FATIGUE (excessive fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site warmth, Pain in extremity
Clinical narrative: arm sore; arm hot and sensitive to the touch; arm red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), INJECTION SITE WARMTH (arm hot and sensitive to the touch) and ERYTHEMA (arm red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm sore), INJECTION SITE WARMTH (arm hot and sensitive to the touch) and ERYTHEMA (arm red). At the time of the report, PAIN IN EXTREMITY (arm sore), INJECTION SITE WARMTH (arm hot and sensitive to the touch) and ERYTHEMA (arm red) outcome was unknown.            No concomitant product use was reported No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: headache; fatigue; slight swelling at the injection site; redness; very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE SWELLING (slight swelling at the injection site), VACCINATION SITE ERYTHEMA (redness) and MYALGIA (very sore arm) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FLUOXETINE, AMLODIPINE and ATORVASTATIN for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE SWELLING (slight swelling at the injection site), VACCINATION SITE ERYTHEMA (redness) and MYALGIA (very sore arm). At the time of the report, HEADACHE (headache), FATIGUE (fatigue), VACCINATION SITE SWELLING (slight swelling at the injection site), VACCINATION SITE ERYTHEMA (redness) and MYALGIA (very sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Hyperhidrosis, Hypersomnia, Illness
Clinical narrative: Tight chest; Coughing; Sweating; Body spasms; Slept for over 24 hours; Really sick; Rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tight chest), COUGH (Coughing), HYPERHIDROSIS (Sweating), MUSCLE SPASMS (Body spasms) and HYPERSOMNIA (Slept for over 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (Rash on arm). On 05-Mar-2021, the patient experienced CHEST DISCOMFORT (Tight chest), COUGH (Coughing), HYPERHIDROSIS (Sweating), MUSCLE SPASMS (Body spasms), HYPERSOMNIA (Slept for over 24 hours) and ILLNESS (Really sick). On 06-Mar-2021, HYPERSOMNIA (Slept for over 24 hours) had resolved. On 07-Mar-2021, CHEST DISCOMFORT (Tight chest), COUGH (Coughing), HYPERHIDROSIS (Sweating), MUSCLE SPASMS (Body spasms) and ILLNESS (Really sick) had resolved. At the time of the report, RASH (Rash on arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Rash
Clinical narrative: Tight chest; Coughing; Sweating; Body spasms; Slept for over 24 hours; Really sick; Rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tight chest), COUGH (Coughing), HYPERHIDROSIS (Sweating), MUSCLE SPASMS (Body spasms) and HYPERSOMNIA (Slept for over 24 hours) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (Rash on arm). On 05-Mar-2021, the patient experienced CHEST DISCOMFORT (Tight chest), COUGH (Coughing), HYPERHIDROSIS (Sweating), MUSCLE SPASMS (Body spasms), HYPERSOMNIA (Slept for over 24 hours) and ILLNESS (Really sick). On 06-Mar-2021, HYPERSOMNIA (Slept for over 24 hours) had resolved. On 07-Mar-2021, CHEST DISCOMFORT (Tight chest), COUGH (Coughing), HYPERHIDROSIS (Sweating), MUSCLE SPASMS (Body spasms) and ILLNESS (Really sick) had resolved. At the time of the report, RASH (Rash on arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Hair was falling out/ Hair was falling out in massive amounts/ Alopecia; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair was falling out/ Hair was falling out in massive amounts/ Alopecia) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported).    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced ALOPECIA (Hair was falling out/ Hair was falling out in massive amounts/ Alopecia). At the time of the report, ALOPECIA (Hair was falling out/ Hair was falling out in massive amounts/ Alopecia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: No specific follow-up information recorded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Pruritus, Rash, Rash pruritic, Scar
Clinical narrative: Occasional hives; Several scars where I scratched; rash on thigh, abdomen and arm; (rash) terribly itchy; raised blisters after scratching the itchy sites; Itchiness around the clock; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites), URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock) and SCAR (Several scars where I scratched) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Pollen allergy, Oral allergy syndrome and Psoriasis. Concomitant products included COLECALCIFEROL (VIT D3) for an unknown indication.   On 26-Feb-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Mar-2021, the patient experienced RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites) and RASH (rash on thigh, abdomen and arm). On an unknown date, the patient experienced URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock) and SCAR (Several scars where I scratched). The patient was treated with CORTISONE for Itchy, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites), URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock), SCAR (Several scars where I scratched) and RASH (rash on thigh, abdomen and arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included cortisone cream on the rash which helped relieve itchiness.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Updated all events outcome from unknown to recovering/resolving and duration for events rash, rash pruritic and blister and first dose information.Added new events urticaria, scar and pruritic and concomitant medication, medical history and second dose information.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Occasional hives; Several scars where I scratched; rash on thigh, abdomen and arm; (rash) terribly itchy; raised blisters after scratching the itchy sites; Itchiness around the clock; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites), URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock) and SCAR (Several scars where I scratched) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy, Pollen allergy, Oral allergy syndrome and Psoriasis. Concomitant products included COLECALCIFEROL (VIT D3) for an unknown indication.   On 26-Feb-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Mar-2021, the patient experienced RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites) and RASH (rash on thigh, abdomen and arm). On an unknown date, the patient experienced URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock) and SCAR (Several scars where I scratched). The patient was treated with CORTISONE for Itchy, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC ((rash) terribly itchy), BLISTER (raised blisters after scratching the itchy sites), URTICARIA (Occasional hives), PRURITUS (Itchiness around the clock), SCAR (Several scars where I scratched) and RASH (rash on thigh, abdomen and arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment included cortisone cream on the rash which helped relieve itchiness.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Updated all events outcome from unknown to recovering/resolving and duration for events rash, rash pruritic and blister and first dose information.Added new events urticaria, scar and pruritic and concomitant medication, medical history and second dose information.